Novavax Inc - Company Profile
Powered by 
All the data and insights you need on Novavax Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Novavax Inc Strategy Report
- Understand Novavax Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Novavax Catalyst Calendar
Proactively evaluate Novavax Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Novavax Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 31 Mar 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 31 Mar 2020 | MAA Filing (EU) | Novavax Inc | NVAX | respiratory syncytial virus vaccine | Infectious Disease | Respiratory Syncytial Virus (RSV) Infections | Company Press Release |
| 01 Mar 2020 | Phase III Trial Completion | Novavax Inc | NVAX | NanoFlu | Infectious Disease | Influenza A Virus, H1N1 Subtype Infections; Influenza A Virus, H3N2 Subtype Infections; Influenzavirus B Infections; Seasonal Influenza | Company Press Release |
| 27 Dec 2019 | Phase II Trial Initiation | Advanced BioScience Laboratories Inc; Novavax Inc; Nucleus Network Ltd; Oak Ridge Institute for Science and Education; Philipps University of Marburg; Q-Pharm Pty Ltd; U.S. Army Medical Research Institute of Infectious Diseases | NVAX | Ebola [Zaire] vaccine; Matrix M adjuvant | Infectious Disease | Ebolavirus Infections (Ebola Hemorrhagic Fever) | GD Estimates |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer